Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02250625 · ClinicalTrials.gov registry record
Study Vitamin D in Healthy Individuals
A clinical trial, sponsored by Fujirebio Diagnostics.
- Completed
- Registry status
- 482
- Enrollment target
NCT02250625: Completed study, sponsored by Fujirebio Diagnostics.
NCT02250625 is a clinical trial that has completed, run by Fujirebio Diagnostics. The registered enrollment target is 482 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02250625 has completed, sponsored by Fujirebio Diagnostics.
- COMPLETED
- Registry status
- 482 participants
- Enrollment target
Study Summary
To obtain sufficient specimens and correlating clinical data from a well-controlled prospective clinical trial collecting specimens from healthy subjects t on vitamin D assays, and to establish a collection of specimens that will support future assay discovery and validation efforts.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 482 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-04 |
What the finished NCT02250625 record still lists
NCT02250625 is an observational study that tracks outcomes without assigning an intervention. The registered 482 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02250625 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02250625 about?
NCT02250625 is a clinical study titled "Study Vitamin D in Healthy Individuals". To obtain sufficient specimens and correlating clinical data from a well-controlled prospective clinical trial collecting specimens from healthy subjects t on vitamin D assays, and to establish a collection of specimens that will support future assay discovery and validation efforts.
What is the current status of trial NCT02250625?
This trial is currently completed. The enrollment target is 482 participants. The study started on 2014-05. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT02250625?
This trial is sponsored by Fujirebio Diagnostics, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04449458 · 482 participants · NA
The Positively Quit Trial for Smoking Cessation
- NCT07079631 · 482 participants · Phase 1
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia